measuregroup/AID313754

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103559470_AID313754_PMID18060776_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103559454_AID313754_PMID18060776_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103505800_AID313754_PMID18060776_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103559457_AID313754_PMID18060776_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103559456_AID313754_PMID18060776_VALUE3
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP37231
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Agonist activity at human PPARgamma assessed as receptor activation by cell based assay relative to rosiglitazone
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103559454 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103559470 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103559457 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103505800 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103559456
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID313754

Total number of triples: 15.